Skip to content

A clinical study to evaluate the effectivenss of vasaguduchyadi ghana vati in the management of essential hypertension

A controlled clinical study to evaluate the efficacy of vasaguduchyadi ghana vati as add on therapy in the management of essential hypertension - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/102253
Enrollment
30
Registered
2026-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Sponsors

Dr Shreyas D
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with age group of 18 TO 70 years irrespective of religion and sex will be selected Subjects falling under category of Pre Hypertension and Stage I without underlying complication according to JNC VIII guidelines of Hypertension Fresh cases and patients on medication Freshly detected Already diagnosed but discontinued the medication voluntarily Patients on antihypertensive medication Both symptomatic and asymptomatic patients Hypertensive patients with well controlled diabetes are included Subjects who are ready to sign the consent form voluntarily are included in the study

Exclusion criteria

Exclusion criteria: Stage II hypertension Any systemic illness that can interfere with the course of treatment will be excluded Pregnant and lactating women Subjects under corticosteroid medications Subjects having history of myocardial infarction stroke

Design outcomes

Primary

MeasureTime frame
Reduction in blood pressure of patients of essential hypertension according to staging mentioned in JNC 8 criteria Change in systolic blood pressure Change in diastolic blood pressure Change in mean arterial pressure Reduction in signs and symptoms of essential hypertension according to severity grading scales of different symptomsTimepoint: 0th day 15th day 30th day 45th day

Secondary

MeasureTime frame
Improvement in quality of life of patients according to Short Form Survey SF 36Timepoint: 0th day 15th day 30th day 45th day

Countries

India

Contacts

Public ContactDr Shreyas D

SRI DHARMASTHALA MANJUNATHESHWARA INSTITUTE OF AYURVEDA AND HOSPITAL BENGALURU

ssomayaji78@gmail.com9448211053

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026